WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinomaAlexander Rialdi, Arvin C. Dar, Julia N. Zhao et al.|Nature Cancer|2023Cited by 27
Aggressive B cell lymphomas retain ATR-dependent determinants of T cell exclusion from the germinal center dark zoneValeria Cancila, Claudio Tripodo, Giorgio Bertolazzi et al.|Journal of Clinical Investigation|2025Cited by 1